Challenges of moving theranostic nanomedicine into the clinic

Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems

(2019) Catarina Silva et al.   Pharmaceutics

Molecularly Engineered Theranostic Nanoparticles for Thrombosed Vessels: H2O2-Activatable Contrast-Enhanced Photoacoustic Imaging and Antithrombotic Therapy

(2018) Eunkyeong Jung et al.   ACS Nano

Recent trends of nanomedicinal approaches in clinics

(2018) Fahima Dilnawaz et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

(2018) Susan Hua et al.   Frontiers in Pharmacology

Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies

(2018) Lisa Accomasso et al.   Frontiers in Pharmacology

Rethinking cancer nanotheranostics

(2017) Hongmin Chen et al.   Nature Reviews Materials

Towards clinically translatable in vivo nanodiagnostics

(2017) Seung-min Park et al.   Nature Reviews Materials

Cancer nanotheranostics: Strategies, promises and impediments

(2016) Moumita Roy Chowdhury et al.   BIOMEDICINE & PHARMACOTHERAPY

Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures

(2016) Héloïse Ragelle et al.   Expert Opinion on Drug Delivery

Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model

(2016) Joshua A. Jackman et al.   Nanomedicine-Nanotechnology Biology and Medicine

Gadolinium polytungstate nanoclusters: a new theranostic with ultrasmall size and versatile properties for dual-modal MR/CT imaging and photothermal therapy/radiotherapy of cancer

(2016) Yuan Yong et al.   NPG Asia Materials

Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs

(2015) Janos Szebeni et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Regulatory aspects on nanomedicines

(2015) Vanessa Sainz et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?

(2015) Tamar Dreifuss et al.   Nanoscale

Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?

(2015) Pedro Pedrosa et al.   Nanomaterials

Nanomedicines: addressing the scientific and regulatory gap

(2014) Sally Tinkle et al.   Annals of the New York Academy of Sciences

Magnetically engineered Cd-free quantum dots as dual-modality probes for fluorescence/magnetic resonance imaging of tumors

(2013) Ke Ding et al.   BIOMATERIALS

Nanotheranostics for personalized medicine

(2012) Simona Mura et al.   ADVANCED DRUG DELIVERY REVIEWS

Theranostic Nanomedicine

(2011) Twan Lammers et al.   ACCOUNTS OF CHEMICAL RESEARCH

Nanomedicine-Challenge and Perspectives

(2009) Kristina Riehemann et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION